Replies to post #692086 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

NWBO is not requesting IRP at MHRA, because they are not commercially approved in some qualifying country.

you are aware of the meaning first assessment right?
In this side note in the article there is talk of meds that are awaiting first assessment


All eligible national Marketing Authorisation applications submitted before 1 January 2024 that were awaiting first assessment